Selected Safety Information
- Safety and efficacy of NEXPLANON have been established in women of reproductive age and are expected to be the same for postpubertal adolescents. However, no studies have been conducted in women less than 18 years of age. Use of this product before menarche is not indicated.
Guide to health plan coverage
Although NEXPLANON is covered by many insurance plans, coverage can vary from one plan to the next.
Each patient will need to check with their insurance provider to determine whether their plan will cover NEXPLANON.
In the process, your patient will also need to find out if it is covered as a medical benefit or as a pharmacy benefit. Typically, NEXPLANON is covered as a medical benefit. Medical benefits cover in-office procedures that include visits, lab work, and medicines or products that they might receive. If NEXPLANON is not covered as a medical benefit, it may be covered as a pharmacy benefit.
Please refer to the health plan coverage guide on the consumer Web site for NEXPLANON.
Selected Safety Information
About NEXPLANON (etonogestrel implant) 68 mg (continued)
- The efficacy of NEXPLANON in women who weighed more than 130% of their ideal body weight has not been defined because such women were not studied in clinical trials. Serum concentrations of etonogestrel are inversely related to body weight and decrease with time after implant insertion. Therefore, NEXPLANON may be less effective in overweight women.
- NEXPLANON does not protect against HIV (AIDS) or other sexually transmitted diseases.
